Rethinking Regulatory Harmonization for Advanced Therapeutics: Streamlining Global Access to Gene, Cell, and RNA-Based Medicines
  The scale and complexity of modern healthcare challenges, from pandemic preparedness to combating antimicrobial resistance and accelerating rare disease therapies, are too vast for any single entity—whether government, industry, or academic institution—to solve alone. This reality has amplified the critical importance of robust public-private partnerships (PPPs) as the...
0 Commentaires 0 Parts 2KB Vue 0 Aperçu